Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Delta-Fly Pharma, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Progress status of DFP-10917 involved clinical studies
First Patient Enrolled in Phase 2/3 Randomized Study of DFP-17729 for Pancreatic Cancer in Japan
Delta-Fly Pharma, Apr-Jun (1Q) Net Income Loss Narrows
Progress status for Phase 1/2 study of DFP-10917 with Venetoclax (VEN) in the 2nd line AML
Delta-Fly Pharma, The Current Fiscal Year's Net Income to Narrow
Announcement of novel patent filing for the DFP-10917 drug product
Announcement for a phase 2/3 study of DFP-17729 to be started
Delta-Fly Pharma, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
Delta-Fly Pharma, Inc., First Half Net Income Loss Widens, July-September Net Income Loss Widens